Bg pattern

CENTILUX 0.25 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CENTILUX 0.25 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: informationfor the user

Centilux 0.25 mg/ml eye drops in solution

Nafazoline

Read the entire leaflet carefully before starting to use this medication, as it contains important information for you.

Follow exactly the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 3 days.

Contents of the leaflet

  1. What Centilux eye drops are and what they are used for
  2. What you need to know before starting to use Centilux eye drops
  3. How to use Centilux eye drops
  4. Possible side effects

5 Conservation of Centilux eye drops

  1. Contents of the package and additional information

1. What Centilux eye drops are and what they are used for

They contain nafazoline as the active ingredient, with decongestant action (produces vasoconstriction or narrowing of the visible blood vessels in the eye).

Centilux is indicated for: Temporary relief of congestion, redness, and mild irritation in the eyes of irritative and/or allergic origin, caused by external agents such as: tobacco smoke, dust, pollution, dry or charged environments, sunlight, chlorinated or sea water, reading or tasks that require prolonged fixation of vision.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use Centilux eye drops

Do not useCentilux:

  • if you are allergic to nafazoline or other adrenergic medications (which, among other actions, can raise blood pressure) or to any of the other components of this medication (included in section 6).
  • if you have narrow-angle glaucoma in the eyes.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Centilux.

You must be cautious if you are in any of the following cases:

  • In case you are being administered certain anesthetics (e.g., halothane, which makes the heart more sensitive to medications of the nafazoline type)
  • If you have bronchial asthma
  • If you have any heart or circulation disease
  • If you have arteriosclerosis in the brain
  • If you have high blood pressure
  • If you have thyroid disease
  • If you have diabetes
  • If you are being treated with MAOI (monoamine oxidase inhibitor) medications (usually antidepressants) or during the two weeks after stopping such treatment
  • Do not use for more than 3 to 5 days
  • Do not wear contact lenses during the use of this medication.

Children

Do not use Centilux in children; safety and efficacy have not been established in children.

Elderly patients

Caution should be exercised in patients over 65 years of age, particularly those with severe heart or circulation diseases.

Other medicationsand Centilux

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

No interactions with other medications are known.

Pregnancy and lactation

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Centilux should only be administered during pregnancy if it is considered absolutely necessary and the potential benefit outweighs the potential risk to the fetus.

Do not use Centilux if you are breastfeeding a baby.

Driving and using machines

This medication may cause temporary vision disturbances. Do not drive or operate machines for a few minutes until the blurry vision disappears.

Centilux contains benzalkonium chloride and phosphates

This medication contains 0.1 mg of benzalkonium chloride per ml.

Benzalkonium chloride can be absorbed by soft contact lenses and may alter their color.

Remove contact lenses before using this medication and wait at least 15 minutes before putting them back on.

Benzalkonium chloride can cause eye irritation, especially if you have dry eye or other corneal diseases (transparent layer on the front of the eye). Consult your doctor if you feel any strange sensation, itching, or pain in the eye after using this medication.

This medication contains 2.2 mg of phosphates per ml.

If you have severe damage to the transparent layer on the front of the eye (cornea), treatment with phosphates, in very rare cases, can cause cloudy patches on the cornea due to calcium.

3. How to use Centilux eye drops

Follow exactly the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.

The recommended dose is:

Ophthalmic route (in the eyes)

  • Adults:

The dose is one or two drops of Centilux administered 2 to 4 times a day in the affected eye(s).

How to use:

  1. Wash your hands and sit in front of a mirror, if possible.
  2. After opening the dropper bottle (vial) for the first time, remove the plastic ring from the seal.
  3. Always be careful not to touch anything with the dropper tip, as it could contaminate the contents of the vial.

Content of the vial.

  1. Hold the vial upside down with one hand.
  2. With the other hand, pull down the lower eyelid of the affected eye and look up, tilting your head back.

Direction of gaze.

  1. Place the dropper tip close to the eye, without touching it, and gently press the base of the vial so that the drops fall into the space between the eye and the eyelid.

Application of the drops.

  1. Gently close your eyes and keep them closed for a few seconds.
  2. Repeat steps 4, 5, and 6 for the other eye, if necessary.
  3. Close the vial well after use.

If you use more than one medication via the ophthalmic route, the applications should be spaced at least 5 minutes apart.

The duration of treatment should not exceed 3-5 days (rebound congestion may occur).

If the symptoms do not resolve within this time period (72 hours), you should consult a doctor who will examine the condition of your eyes.

If you use more Centilux than you should

Due to the characteristics of this medication, intoxication phenomena are not expected with topical use at the recommended doses.

Taking a considerably larger amount of Centilux than the recommended dose, for example, if you accidentally swallow Centilux, can cause serious side effects that affect the heart and blood circulation. Symptoms may include: reduced heart rate (bradycardia), acute headache, nausea, vomiting, respiratory problems, increased heart rate (tachycardia), and chest pain.

An overdose can be eliminated by rinsing the eyes with warm water. Do not apply more drops until it is time for the next dose.

In case of accidental ingestion of the contents of a vial, especially in children, signs of central nervous system (CNS) effects may appear, such as significant sedation, CNS depression, decreased body temperature, and coma.

With very high doses of nafazoline, side effects may occur in the heart or circulation.

Other symptoms that may appear if the medication is accidentally ingested, especially by children, are: nausea, vomiting, lethargy, difficulty breathing, etc.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, go to a medical center, or call the Toxicology Information Service, Telephone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Centilux

Do not use a double dose to make up for the forgotten dose.

Apply a single dose as soon as you remember. If it is almost time for the next dose, wait for the next dose and continue with your regular regimen.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

It has been observed that the following may occur: dilation of the pupil, increased pressure inside the eye (intraocular), effects due to absorption into the body (increases in blood pressure, cardiac disorders, and increased blood sugar), headache, and nausea.

Rarely, itching has been observed after application.

Possible appearance, with low frequency, of continuous redness and eye irritation.

With unknown frequency: conjunctivitis, eye pain.

In very rare cases: opaque areas in the cornea.

In predisposed patients and with the use of a greater amount or frequency than recommended, palpitations, tremors, weakness, and sweating may occur.

An allergic reaction to one of the components may also occur.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Centilux eye drops

Keep this medication out of sight and reach of children.

Do not store at a temperature above 25°C.

Keep the container in the outer packaging to protect it from light.

Do not use this medication after the expiration date shown on the container and carton after EXP. The expiration date is the last day of the month indicated.

Do not use this medication if you notice that the solution changes color or becomes cloudy.

The vial must be discarded four weeks after the first opening.

Medications should not be thrown down the drain or into the trash. Deposit the containers and medications you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.

6. Contents of the package and additional information

Composition of Centilux

  • The active ingredient is nafazoline hydrochloride. One ml of eye drops contains 0.25 mg of nafazoline hydrochloride (0.025%).
  • The other components are: benzalkonium chloride, sodium chloride, disodium phosphate dodecahydrate, sodium phosphate monohydrate, methylthioninium chloride (methylene blue), and purified water.

Appearance of the product and contents of the package

The medication is an eye drop solution; it is a blue liquid.

It is presented in a dropper bottle (plastic vial) with 10 ml of eye drop solution.

Marketing authorization holder and manufacturer

Marketing authorization holder

Reva Health Europe, S.L.

Pl. Ausiàs March, 1, 4-6

08195 Sant Cugat del Vallès-Spain

Manufacturer

Tubilux Pharma S.P.A.

VIA COSTA RICA, 20/22

00071-POMEZIA (ROMA)

Date of the last revision of this leaflet:June 2025

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for CENTILUX 0.25 mg/ml EYE DROPS SOLUTION

Discuss questions about CENTILUX 0.25 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CENTILUX 0.25 mg/ml EYE DROPS SOLUTION?
CENTILUX 0.25 mg/ml EYE DROPS SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CENTILUX 0.25 mg/ml EYE DROPS SOLUTION?
The active ingredient in CENTILUX 0.25 mg/ml EYE DROPS SOLUTION is naphazoline. This information helps identify medicines with the same composition but different brand names.
Who manufactures CENTILUX 0.25 mg/ml EYE DROPS SOLUTION?
CENTILUX 0.25 mg/ml EYE DROPS SOLUTION is manufactured by Reva Health Europe S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CENTILUX 0.25 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CENTILUX 0.25 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CENTILUX 0.25 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (naphazoline) include ALERGOFTAL 0.25 mg/ml + 5 mg/ml EYE DROPS SOLUTION, LUMOBRY 0.25 mg/ml EYE DROPS SOLUTION, MIRAZUL 1.25 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media